World J Gastroenterol. 2010 Jan 14;16(2):139-42. doi: 10.3748/wjg.v16.i2.139.
Clostridium difficile (C. difficile) is now the leading cause of nosocomial diarrhea in the USA, accounting for 30% of patients with antibiotic-associated diarrhea, 70% of those with antibiotic-associated colitis, and most cases of pseudomembranous colitis. The organism has evolved over the last 8 years to become more virulent and resistant to antimicrobials (NAP1/027 strain) causing a more severe form of the disease that has increased mortality and healthcare costs. While it is generally accepted that the problem results from the overuse of antibiotics, and in particular second and third generation cephalosporins, fluoroquinolones and macrolides, recent studies suggest that acid suppression with proton pump inhibitors (PPIs) may be equally culpable. A further common, but less recognized, etiological factor is the prolonged use of elemental diets. Such diets are totally absorbed within the small intestine and therefore deprive the colonic microbiota of their source of nutrition, namely dietary fiber, fructose oligosaccharides, and resistant starch. The resultant suppression of colonic fermentation leads to suppression of the "good" bacteria, such as butyrate-producers (butyrate being essential for colonic mucosal health), and bifidobacteria and the creation of a "permissive" environment for C. difficile colonization and subsequent infection. Based on this analysis, the best chance of suppressing the emerging C. difficile epidemic is to adopt a 3-pronged attack consisting of (1) avoidance of the use of prophylactic antibiotics, (2) the avoidance of prophylactic PPIs, and (3) the conversion of elemental diet feeding to a diet containing adequate indigestible carbohydrate after the first week of critical illness. In this review, we highlight the rising worldwide incidence of C. difficile associated diarrhea and the role played by non-residue diets in destabilizing the colonic microbiota.
艰难梭菌(C. difficile)现在是美国医院性腹泻的主要原因,占抗生素相关性腹泻患者的 30%,抗生素相关性结肠炎的 70%,以及大多数伪膜性结肠炎的病例。该病原体在过去 8 年中发生了进化,变得更加毒力和对抗菌药物耐药(NAP1/027 株),导致疾病的更严重形式,增加了死亡率和医疗保健成本。虽然人们普遍认为问题是由于抗生素的过度使用,特别是第二代和第三代头孢菌素、氟喹诺酮类和大环内酯类药物,但最近的研究表明,质子泵抑制剂(PPIs)的酸抑制可能同样负有责任。另一个常见但不太被认识的病因是长期使用元素饮食。这种饮食在小肠内完全被吸收,因此剥夺了结肠微生物群的营养来源,即膳食纤维、低聚果糖和抗性淀粉。结肠发酵的抑制导致“有益”细菌的抑制,如丁酸产生菌(丁酸对结肠黏膜健康至关重要)和双歧杆菌,并为艰难梭菌定植和随后的感染创造了一个“许可”的环境。基于此分析,抑制艰难梭菌流行的最佳机会是采取三管齐下的策略,包括(1)避免预防性使用抗生素,(2)避免预防性使用 PPIs,以及(3)在危重病的第一周后,将元素饮食喂养转换为含有足够不可消化碳水化合物的饮食。在这篇综述中,我们强调了艰难梭菌相关腹泻在全球范围内的发病率上升,以及非残渣饮食在破坏结肠微生物群方面的作用。